Available
Logo Viatim

ViATIM® OVERVIEW

ViATIM provides simultaneous active immunisation against hepatitis A and typhoid fever via an easy to use dual chamber syringe.

Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.

ViATIM Prescribing information

View the ViATIM SmPC

Why help protect your patients with ViATIM?

Being able to help protect your patients against hepatitis A and typhoid fever in a single injection is convenient for your patients who may require a number of other injections ahead of their travels.

ViATIM helps provide protection against both hepatitis A and typhoid fever. A single dose from a dual chamber syringe provides protection against these infectious diseases for up to 3 years by day 14.1

Seroprotection rates with ViATIM are consistent with those from monovalent vaccines administered separately.1

 

 

Presentation

Schedule

Further doses

Age range

 

Logo Viatim

1 ml prefilled dual-chamber syringe

Available in 1 syringe packs

1 dose

In order to provide long-term protection against infection caused by the hepatitis A virus, a second dose (booster) of an inactivated hepatitis A vaccine should be given.

• In subjects who have received one dose of Viatim®:
- either a dose of monovalent hepatitis A vaccine should be given within 36 months and preferably within 6 to 12 months or, if continued protection against typhoid is also required, a second dose of Viatim® may be given provided that approximately 36 months have elapsed since the first dose

• In subjects who have received one dose of monovalent hepatitis A vaccine:
- Viatim® may be used to provide the second dose (booster) of hepatitis A vaccine if protection against typhoid fever is also desirable. It should be given within 36 months of the hepatitis A vaccine and preferably within 6 to 12 months

In subjects who remain at risk of typhoid fever, revaccination against typhoid fever should be carried out with a single dose of a typhoid Vi polysaccharide vaccine every 3 years

16 years+

 

References:

  1. Sanofi Pasteur Hepatitis A (inactivated, absorbed) & Typhoid Polysaccharide Vaccine Summary of Product Characteristics. January 2018

ViATIM SmPC

Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.

ViATIM Prescribing information

View the ViATIM SmPC

Materials Ordering Online – Giving You Access to A Range Of Support Materials

Sanofi Pasteur is committed to providing you and your patients with a comprehensive range of support materials, including disease awareness patient leaflets and in-surgery display items.

• Simply visit https://sanofi.medisa.com

• Select the user group which best describes your role in your organisation

• Narrow your search by selecting the appropriate disease area

• Select which materials you would like to receive and how many

• Log-in or register to create an account

• Confirm your order

VISIT MEDISA

 

Date of preparation: November 2018 | SAGB.MIS.18.08.1323x